Innate Pharma (IPHA) Retained Earnings (2017 - 2025)
Innate Pharma posted quarterly Retained Earnings of -$57.2 million for Q4 2025, up 84.1% year-on-year from -$31.1 million in Q4 2024, and down 4335.41% on a QoQ basis from $1.4 million in Q2 2025.
Innate Pharma (IPHA) has 9 years of Retained Earnings data on file, last reported at -$57.2 million in Q4 2025.
- For the quarter ending Q4 2025, Retained Earnings rose 84.1% year-over-year to -$57.2 million; the trailing twelve-month figure through Dec 2025 stood at -$57.2 million (up 84.1% YoY), and the FY2025 full-year result was -$57.2 million, up 84.1% from the prior year.
- Retained Earnings for Q4 2025 stood at -$57.2 million, down from $1.4 million in the prior quarter.
- Across five years, Retained Earnings topped out at $1.4 million in Q2 2025 and bottomed at -$360.0 million in Q4 2024.
- The 5-year median for Retained Earnings is $451434.5 (2021), against an average of -$42.0 million.
- The widest annual swing landed in 2023, when Retained Earnings surged 282.33%; it then tumbled 4319.99% in 2024.
- A 5-year view of Retained Earnings shows it stood at $521650.8 in 2021, then jumped by 60.18% to $835582.6 in 2022, then sank by 1074.75% to -$8.1 million in 2023, then sank by 4319.99% to -$360.0 million in 2024, then surged by 84.1% to -$57.2 million in 2025.
- The last three Retained Earnings figures came in at -$57.2 million (Q4 2025), $1.4 million (Q2 2025), and -$360.0 million (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,638,563.89 Bn | 1,638,563.89 Bn | - | -211.85 Mn |
| 2 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - | -153.89 Mn |
| 3 | Legend Biotech | 2,937.00 Bn | 2,936.10 Bn | 242.10 Mn | 1.00 Bn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | -438.66 Mn |
| 5 | Akari Therapeutics | 2,169.69 Bn | 2,169.69 Bn | - | -279.00 Mn |
| 6 | Vertex Pharmaceuticals | 110.41 Bn | 103.16 Bn | 2.59 Bn | 14.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.44 Bn | 57.69 Bn | 3.31 Bn | 36.42 Bn |
| 8 | Evaxion A | 65.44 Bn | 65.42 Bn | - | 130.89 Mn |
| 9 | Alnylam Pharmaceuticals | 39.53 Bn | 36.52 Bn | 959.66 Mn | -24.89 Mn |
| 10 | Innate Pharma | 199.64 Mn | 199.64 Mn | - | -57.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -57.24 Mn |
| Jun 30, 2025 | 1.35 Mn |
| Dec 31, 2024 | -360.00 Mn |
| Jun 30, 2024 | 381,218.20 |
| Dec 31, 2023 | -8.14 Mn |
| Jun 30, 2023 | 1.16 Mn |
| Dec 31, 2022 | 835,582.59 |
| Jun 30, 2022 | 303,044.10 |
| Dec 31, 2021 | 521,650.75 |
| Jun 30, 2021 | 861,054.08 |
| Dec 31, 2020 | 423,262.90 |
| Jun 30, 2020 | -568.00 Mn |
| Dec 31, 2019 | -522,450.98 |
| Dec 31, 2018 | -157.47 Mn |
| Dec 31, 2017 | -106.09 Mn |